🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Endurance Trial is a phase IV open label clinical study to assess the n...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02297204
Treatments Being Tested
To assess the efficacy of intravitreal (IVT) administration of aflibercept ...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-19
Trial ID
NCT02305238
Treatments Being Tested
The study is designed for multi-center,randomized,double-masked,active-cont...
Status
Active Not Recruiting
Location
Shanghai General Hospital
Start Date
2023-09-21
Trial ID
NCT05972473
Treatments Being Tested
Retinal nonperfusion drives vision-threatening complications such as pathol...
Status
Completed
Location
Asan medical center
Start Date
2016-04-14
Trial ID
NCT03006081
Treatments Being Tested
This study is designed to evaluate the safety and efficacy of every 2 week ...
Status
Unknown
Location
Tennessee Retina
Start Date
2018-04
Trial ID
NCT03468296
Treatments Being Tested
Oculgen has begun a study of an investigational drug called OCUL101 as a po...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-17
Trial ID
NCT07520318
Treatments Being Tested
To determine the efficacy of intravitreally (IVT) administered VEGF Trap-Ey...
Status
Completed
Location
Multiple Locations
Start Date
2013-02
Trial ID
NCT01783886
Multicenter randomized trials have demonstrated the safety and efficacy of ...
Status
Unknown
Location
Maisonneuve Rosemont Hospital
Start Date
2016-11
Trial ID
NCT02924987
Treatments Being Tested
This is a single-arm, multicenter study to evaluate clinical usability of a...
Status
Completed
Location
East Florida Eye Institute
Start Date
2026-05-13
Trial ID
NCT07501052
Treatments Being Tested
This is a multi-center, randomized, double-blind, active-controlled study t...
Status
Completed
Location
Innovent Biologics (Suzhou) Co,Ltd.
Start Date
2021-04-28
Trial ID
NCT04820452
Treatments Being Tested